ESTRO 2024 - Abstract Book

S1749

Clinical - Lung

ESTRO 2024

Conclusion:

This multimodal learning framework leads could predict patient’s early response to treatment. This could guide the development of new and more effective therapeutic AI-based approaches and could represent an effective and innovative step forward in personalised medicine.

Keywords: radiomics, NSCLC, precision medicine,

2606

Digital Poster

Prolonging TKI treatment after limited progression with local therapy in ALK- or EGFR-NSCLC

Michael RT Laursen 1 , Anna M Nielsen 1 , Rawia FG Jensen 1 , Jon L Andersen 1 , Gitte F Persson 1,2

1 Copenhagen University Hospital, Herlev and Gentofte, Department of Oncology, Copenhagen, Denmark. 2 Faculty of Medical Sciences, University of Copenhagen, Copenhagen,, Department of Clinical Medicine, Copenhagen, Denmark